Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy.

Raphaël MetzAurore RauscherLoig Vaugier Stéphane SupiotFranck DrouetLoic Campion Caroline Rousseau

Published in: Cancers (2023)

Routine use of FCH or PSMA PET/CT in hormone-sensitive PC showed an advantage for using PSMA PET/CT to guide MDT in terms of BR-FS and ADT-FS in patients with low PSA value. Prospective studies are needed to confirm these hypotheses.

Keyphrases

pet ct
prostate cancer
clinical practice
positron emission tomography
case control
mesenchymal stem cells
smoking cessation